WebbSharon Mates has been the Chairman of the board of directors, President and Chief Executive Officer of ITI since June 2002. Dr. Mates co-founded ITI in May 2002. Prior to … WebbIntra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.
Biotech Sector Working Fast to Combat Alzheimer
Webb4 apr. 2024 · The company was founded by Paul Greengard and Sharon Mates in 2002 and is headquartered in New York, NY. ... Sharon Mates PhD. Chairman, President & Chief Executive Officer. Rene E Salas. Webb21 dec. 2024 · The drug has shown a consistently favorable profile on weight, extrapyramidal symptoms, and cardiometabolic parameters, according to Sharon Mates, PhD, chairman and CEO of Intra-Cellular Therapies. 1 grantsburg high school staff
Biography of Sharon Mates - The Official Board
Webb23 dec. 2024 · Intra-Cellular Therapies announced early Monday morning lumateperone (CAPLYTA) had received approval from the FDA and the company expects the treatment … WebbSharon Mates, Intra-Cellular Therapies Inc: Profile and Biography - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people … Webb26 juli 2007 · "These programs have a novel combination of pharmacologic properties, that have the potential to define the future of antipsychotic drug therapy and treatment of sleep maintenance disorders," states Sharon Mates, PhD, the company’s chairman and CEO. chipits chocolate chip cookies recipe